Dirk Pleimes

Myelo Therapeutics GmbH develops innovative treatments in areas of high unmet medical needs. Currently Myelo001 is developed in the therapeutic area of oncology.

Global Medical Lead for therapeutic area of Ophthalmology and Neurology and Head of Medical Affairs Europe and Canada Ophthalmology. Global launch preparation and execution for the indication of central and branch retinal vein occlusion for multi-billion euro biologic. • CRVO Launch and long-term strategy for CRVO/ BRVO indications. • Global Market Access (Pricing, Health Economic Outcomes, Advocacy) liason for global medical affairs

Director, responsible for the therapeutic area of Neurology for Global Medical Affairs and European Medical Affairs. Chair of the Global Medical Affairs Team. Directly responsible for ~ 5 Mio USD cost center and functional matrix reports of Global and EU Medical Affair Physicians / Employees. • Shifted strategic direction of global medical affairs team to customer and outcome focus • Optimized communication flow and efficiency in therapeutic area. • Reprioritization of Medical Strategy

Bayer Pharmaceuticals (2009 to 2011, Montville/Berlin) • Study physician for Phase III follow-up clinical trial, Global Project Manager for strategic workstream across Medical Affairs • Excellent track record of brand related publications in the role of Global Publication Strategy Lead Neurology • Implemented globally best practice program for customer-focused medical activities

Product Manager for Neurology Brand (Multiple Sclerosis, Parkinson, Sleep) responsible for Marketing Strategy, Patient Support Program and Publication Strategy • Increased overall sales of Neurology brand from 160 Million to 189 Million Euros in Germany (2009) • Broadened Marketing Contribution to brand success delivering crucial packaging strategy • Researched and co-implemented payer program in changing Market Access environment in Germany

Consultant Physician for Clinical Development Phase I-III Studies (Berlin, Germany)

Medicine, Public Health, Clinical and Molecular Research